Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.

Rhode Island Fertility Coverage Bill – Plain English Summary

This bill would update Rhode Island's existing health insurance rules to expand coverage related to fertility care. Specifically, it would require health insurance plans to cover ovulation-enhancing drugs and related medical services when a doctor determines they are medically necessary for a patient. This builds on current state law that already requires insurers to cover fertility diagnostics, fertility preservation services, and fertility treatments more broadly.

The bill primarily affects Rhode Islanders who have private health insurance and are experiencing difficulty conceiving or ovulating. For patients in this situation, the change could mean that medications prescribed to help stimulate or regulate ovulation — along with the doctor visits and services tied to that treatment — would need to be covered by their insurance plan rather than paid entirely out of pocket. This could make fertility-related care more financially accessible for people who need it.

For insurance companies, the bill would create a new legal obligation to include these specific drugs and services in their coverage offerings, which could affect how they structure their plans and premiums. Employers and individuals who purchase health plans in Rhode Island may also see indirect effects depending on how insurers respond to the expanded requirements.

As of now, the bill has been introduced and referred to the House Health & Human Services Committee, where it has been scheduled for hearings but has not yet advanced further. The committee has recommended holding it for additional study, meaning it is still in the early stages of the legislative process and has not become law.